Happy to get our preclinical CRO services expanding, with clinical chemistry tests. Analysis of markers in body fluids (such as blood, serum, or plasma), is a crucial component in the detection, treatment, and management of diseases and health disorders and can greatly compliment preclinical BD or efficacy studies, toward the overall evaluation of novel compounds. Having such a set-up in-house, also allows for the analysis of radioactive samples, for the evaluation of radioisotopic therapy candidates.
23 February 2023